Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

NBI-74330

SKU: orb3027292

Description

NBI-74330 is a high-affinity CXCR3 antagonist that inhibits the binding of CXCR3 to its ligands CXCL10 and CXCL11, reduces the formation of atherosclerotic plaques in LDL receptor-deficient mice, and decreases the migration of CD4+ T cells and macrophages to the peritoneum.

Research Area

Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number855527-92-3
MW605.58
Purity99.37% (May vary between batches)
FormulaC32H27F4N5O3
SMILES[C@@H](N(CC=1C=CC=NC1)C(CC2=CC(C(F)(F)F)=C(F)C=C2)=O)(C)C=3N(C(=O)C=4C(N3)=NC=CC4)C5=CC=C(OCC)C=C5
TargetCXCR
SolubilityDMSO:80 mg/mL (132.1 mM);10% DMSO+90% Corn Oil:3.3 mg/mL (5.45 mM)

Bioactivity

Target IC50
[125I]-CXCL10-CXCR3:1.5 nM (Ki, in CXCR3-CHO cell membranes)|[125I]-CXCL11-CXCR3:3.2 nM (Ki, in CXCR3-CHO cell membranes)
In Vivo
Methods: DBA/1J mice were treated with NBI-74330 (100 mg/kg) in a collagen-induced arthritis (CIA) model. Arthritis scores and histopathological changes were assessed. Flow cytometry was used to investigate the effects of NBI-74330 on Th1 (IFN-γ, TNF-α, T-bet, STAT4, Notch-3, and RANKL), Th17 (IL-21, IL-17A, STAT3, and RORγt), and Th22 (IL-22) cell expression in splenic CD4 and CXCR3 T cells. RT-PCR was used to assess mRNA levels of IFN-γ, TNF-α, T-bet, RANKL, IL-17A, RORγt, and IL-22 in knee joint tissues. ELISA was used to measure serum protein levels of IFN-γ, TNF-α, and IL-17A. Results: The severity of arthritis scores and histological severity of inflammation were significantly reduced in NBI-74330-treated CIA mice. The percentages of CD4IFN-γ, CD4TNF-α, CD4T-bet, CD4STAT4, CD4Notch-3, CXCR3IFN-γ, CXCR3TNF-α, CXCR3T-bet, CXCR3STAT4, CXCR3Notch-3, CD4RANKL, CD4IL-21, CD4IL-17A, CD4STAT3, CD4RORγt, and CD4IL-22 cells were decreased in NBI-74330-treated CIA mice. In addition, NBI-74330 treatment downregulated the mRNA levels of IFN-γ, TNF-α, T-bet, RANKL, STAT3, IL-17A, RORγt, and IL-22.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

NBI74330

Similar Products

  • rac-NBI-74330 [orb1701726]

    97.85% (May vary between batches)

    473722-68-8

    605.58

    C32H27F4N5O3

    100 mg, 1 mg, 5 mg, 10 mg, 25 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

NBI-74330 (orb3027292)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 100.00
5 mg
$ 180.00
1 ml x 10 mM (in DMSO)
$ 220.00
10 mg
$ 270.00
25 mg
$ 440.00
50 mg
$ 820.00
100 mg
$ 1,270.00
200 mg
$ 1,690.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry